+58.6%
CVE vs IVZ
+122.1%
-63.5%
-49.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | IVZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | -8.0% | +5.3% | -0.9% |
| 7D | -14.1% | -6.7% | -7.4% | -12.8% |
| 30D | -11.6% | -10.9% | -0.8% | -9.4% |
| 3M | 0.0% | -14.8% | +14.9% | +3.5% |
| 6M | -8.4% | +2.4% | -10.8% | -10.7% |
| YTD | +65.9% | +5.4% | +60.5% | +58.5% |
| 1Y | +69.4% | +19.6% | +49.9% | +53.6% |
| All | +58.6% | +122.1% | -63.5% | +4.9% |
Cumulative growth
Daily Returns
Daily percentage return beside IVZ.
Daily Out/Under-Performance
Portfolio return minus IVZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling